These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11496945)

  • 1. Fractal volume of drug distribution: it scales proportionally to body mass.
    Karalis V; Claret L; Iliadis A; Macheras P
    Pharm Res; 2001 Jul; 18(7):1056-60. PubMed ID: 11496945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug disposition viewed in terms of the fractal volume of distribution.
    Karalis V; Macheras P
    Pharm Res; 2002 May; 19(5):696-703. PubMed ID: 12069175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced maximal metabolic rate scales with muscle aerobic capacity.
    Weibel ER; Hoppeler H
    J Exp Biol; 2005 May; 208(Pt 9):1635-44. PubMed ID: 15855395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimensional analysis revisited.
    Günther B; Morgado E
    Biol Res; 2003; 36(3-4):405-10. PubMed ID: 14631872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.
    Mahmood I
    J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.
    Hutchaleelaha A; Chow HH; Mayersohn M
    J Pharm Pharmacol; 1997 Feb; 49(2):178-83. PubMed ID: 9055191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.
    Huang Q; Gehring R; Tell LA; Li M; Riviere JE
    J Vet Pharmacol Ther; 2015 Jun; 38(3):214-26. PubMed ID: 25333341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fractal geometry of nutrient exchange surfaces does not provide an explanation for 3/4-power metabolic scaling.
    Painter PR
    Theor Biol Med Model; 2005 Aug; 2():30. PubMed ID: 16095536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and interspecies scaling of recombinant human factor VIII.
    Mordenti J; Osaka G; Garcia K; Thomsen K; Licko V; Meng G
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):75-8. PubMed ID: 8560482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics.
    Macheras P
    Pharm Res; 1996 May; 13(5):663-70. PubMed ID: 8860420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duality in physiological time: Euclidean and fractal.
    Günther B; Morgado E
    Biol Res; 1996; 29(3):305-11. PubMed ID: 9278701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of basic principles of fractals and their application to pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Feb; 102(2):761-71. PubMed ID: 23233148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
    Caldwell GW; Masucci JA; Yan Z; Hageman W
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic parameters for interspecies scaling using allometric techniques.
    Hayton WL
    Health Phys; 1989; 57 Suppl 1():159-64. PubMed ID: 2606679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradil.
    Marsh RE; Tuszyński JA
    Pharm Res; 2006 Dec; 23(12):2760-7. PubMed ID: 17063399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.